Japan launches first 바카라사이트 유니벳 treatment combining stem cell treatment, kicking off a USD 30 billion cell therapy market
[by Ji, Yong Jun] CHA Medical Center of CHA University announced on April 29 that it has become the first infertility center in Korea to enter the Japanese market by affiliating with ‘HART Clinic,’ a major infertility treatment center in Japan that treats approximately 1,200 infertile patients annually. The medical center further stated that it will be the first in Japan to offer stem cell-based infertility treatment and that a business integration agreement has been signed with HART Clinic.
The signing ceremony was attended by key global representatives from 바카라사이트 유니벳 Medical Center, including 바카라사이트 유니벳 Kwang-ryeol, Director of 바카라사이트 유니벳 Medical Center and Bio Group Global Research Institute; 바카라사이트 유니벳 Won-tae, President of 바카라사이트 유니벳 University of Medical Sciences; Choi Suk-yoon, Vice President of 바카라사이트 유니벳 Biotech; Yoon Do-heum, Director of 바카라사이트 유니벳 Medical Center; Yoon Kyung-wook, CEO of 바카라사이트 유니벳 Healthcare; Han Ki-won, President of 바카라사이트 유니벳 Biotech Global Business Division; Oka Chikahiro, Director of HART Clinic; Oka Kazuhiko, Vice President of HART Clinic; Adnan Catakovic, CEO of 바카라사이트 유니벳 Medical Center Australia; Teck Liang Beng, CEO of Singapore Medical Group; and Jeong Min-soo, CEO of 바카라사이트 유니벳 Healthcare Singapore.
According to the Korea Insurance Research Institute (KIRI), one in four couples in Japan has undergone 바카라사이트 유니벳 treatment, and the demand for egg freezing among unmarried women continues to rise. To alleviate the financial burden of 바카라사이트 유니벳 procedures, insurance products covering 바카라사이트 유니벳 treatment costs are actively being developed in the country. Despite these efforts, the average pregnancy success rate for 바카라사이트 유니벳 treatments in Japan remains at approximately 23%.
바카라사이트 유니벳 Medical Center aims to increase pregnancy success rates by integrating infertility treatment technologies with cell therapy. Specifically, the center plans to implement parallel treatment using various types of stem cells for women over the age of 35 undergoing infertility treatment, in cooperation with 바카라사이트 유니벳 Biotech’s R&D division. This is expected to mark the first case of direct stem cell injection into the ovaries, not only in Korea and Japan, but also on a global scale.
바카라사이트 유니벳 Medical Center has already conducted multiple clinical studies on cell therapy for infertility treatment, including numerous successful procedures using PRP (platelet-rich plasma) injections to address ovarian dysfunction. PRP, which contains various growth factors, is known as a regenerative therapy that promotes extracellular matrix remodeling as well as stem cell differentiation and proliferation. Building on this experience, 바카라사이트 유니벳 Medical Center plans to actively pursue full-scale stem cell treatment in Japan, where the regulatory environment for conducting clinical trials in this area is relatively easy.
“Japan has more flexible government regulations in the areas of infertility treatment and cell therapy compared to Korea, resulting in distinct differences in regulatory frameworks,” explained Nam Su-youn, head of R&D at 바카라사이트 유니벳 Biotech. “By applying stem cell therapy to infertility treatment, we aim not only to improve pregnancy success rates but also to generate new research publications and advance technological development.” HART Clinic Director Oka commented, “We will make every effort to ensure that both institutions collaborate effectively and achieve world-class outcomes in the future.”
바카라사이트 유니벳 Medical Center’s Infertility Center is recognized as one of the ‘world’s top three infertility centers,’ operating six women’s medical research centers in Korea (Gangnam, Seoul Station, Bundang, Ilsan, Jamsil, and Daegu) and 31 infertility clinics in major cities throughout Australia. The center has a history of pioneering achievements in reproductive medicine, including the world's first successful in vitro fertilization pregnancy using immature eggs in 1988 and the development of the world’s first vitrified egg cryopreservation method in 1998. In 1999, it established the world's first egg bank. This innovation gained global recognition and spurred rapid advancement in the field after the American Society for Reproductive Medicine in Hawaii officially acknowledged egg banking as a method of fertility preservation in 2014.
"The infertility center is at the forefront of the development of infertility and reproductive medicine, demonstrating high pregnancy success rates through the expertise of our medical staff, world-class researcher team, advanced culture technologies, and preimplantation genetic diagnosis (PGT)," a 바카라사이트 유니벳 Medical Center official stated.